No more Mr. Niceguy. It started as “better guidance” for prescribers as concerns mounted that the over-prescription of opioid pain medications was feeding a sharp rise in addiction to illicit forms, including street-sourced pills and heroin. But it has turned into well-coordinated federal and state enforcement actions against physicians and nurses, as well as their practices and hospitals where they practice. Here are the key lessons The Greeley Company has learned from performing external peer review of pain management cases.
Editor’s Note: the blog post originally appeared on The Greeley Company’s website.
To view the full blog post, please click here.
News from our Partners
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
